| Bioactivity | Puxitatug samrotecan drug-linker (AZD8205 drug-linker) is part of the drug-linker conjugate for ADC. Puxitatug samrotecan drug-linker contains a degradable ADC linker and a topoisomase I inhibitor (HY-13631)[1]. |
| CAS | 3025787-81-6 |
| Formula | C60H84N8O20S |
| Molar Mass | 1269.42 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Conilh L, et al. Payload diversification: a key step in the development of antibody–drug conjugates[J]. Journal of Hematology & Oncology, 2023, 16(1): 3. |
Puxitatug samrotecan drug-linker
CAS: 3025787-81-6 F: C60H84N8O20S W: 1269.42
Puxitatug samrotecan drug-linker (AZD8205 drug-linker) is part of the drug-linker conjugate for ADC. Puxitatug samroteca
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.